292 related articles for article (PubMed ID: 19809054)
1. The intersection of risk and benefit: is warfarin anticoagulation suitable for atrial fibrillation in patients on hemodialysis?
Sood MM; Komenda P; Sood AR; Rigatto C; Bueti J
Chest; 2009 Oct; 136(4):1128-1133. PubMed ID: 19809054
[TBL] [Abstract][Full Text] [Related]
2. Outcomes After Warfarin Initiation in a Cohort of Hemodialysis Patients With Newly Diagnosed Atrial Fibrillation.
Shen JI; Montez-Rath ME; Lenihan CR; Turakhia MP; Chang TI; Winkelmayer WC
Am J Kidney Dis; 2015 Oct; 66(4):677-88. PubMed ID: 26162653
[TBL] [Abstract][Full Text] [Related]
3. Warfarin use and the risk of mortality, stroke, and bleeding in hemodialysis patients with atrial fibrillation.
Kai B; Bogorad Y; Nguyen LN; Yang SJ; Chen W; Spencer HT; Shen AY; Lee MS
Heart Rhythm; 2017 May; 14(5):645-651. PubMed ID: 28185918
[TBL] [Abstract][Full Text] [Related]
4. Anticoagulants in patients with atrial fibrillation and end-stage renal disease.
Brimble KS; Ingram AJ; Eikelboom JW; Hart RG
Postgrad Med; 2012 Nov; 124(6):17-25. PubMed ID: 23322135
[TBL] [Abstract][Full Text] [Related]
5. Use of Oral Anticoagulation in the Management of Atrial Fibrillation in Patients with ESRD: Con.
Keskar V; Sood MM
Clin J Am Soc Nephrol; 2016 Nov; 11(11):2085-2092. PubMed ID: 27797891
[TBL] [Abstract][Full Text] [Related]
6. Association between warfarin use and incidence of ischemic stroke in Japanese hemodialysis patients with chronic sustained atrial fibrillation: a prospective cohort study.
Wakasugi M; Kazama JJ; Tokumoto A; Suzuki K; Kageyama S; Ohya K; Miura Y; Kawachi M; Takata T; Nagai M; Ohya M; Kutsuwada K; Okajima H; Ei I; Takahashi S; Narita I
Clin Exp Nephrol; 2014 Aug; 18(4):662-9. PubMed ID: 24113782
[TBL] [Abstract][Full Text] [Related]
7. Dabigatran and rivaroxaban use in atrial fibrillation patients on hemodialysis.
Chan KE; Edelman ER; Wenger JB; Thadhani RI; Maddux FW
Circulation; 2015 Mar; 131(11):972-9. PubMed ID: 25595139
[TBL] [Abstract][Full Text] [Related]
8. [Atrial fibrillation and anticoagulation in hemodialysis patients: A complex decision].
Delanaye P; Bouquegneau A; Dubois BE; Sprynger M; Mariat C; Krzesinski JM; Lancellotti P
Nephrol Ther; 2017 Apr; 13(2):59-66. PubMed ID: 28216253
[TBL] [Abstract][Full Text] [Related]
9. Warfarin use and incidence of stroke in Japanese hemodialysis patients with atrial fibrillation.
Yodogawa K; Mii A; Fukui M; Iwasaki YK; Hayashi M; Kaneko T; Miyauchi Y; Tsuruoka S; Shimizu W
Heart Vessels; 2016 Oct; 31(10):1676-80. PubMed ID: 26646256
[TBL] [Abstract][Full Text] [Related]
10. Warfarin Use in Patients With Atrial Fibrillation Undergoing Hemodialysis: A Nationwide Population-Based Study.
Yoon CY; Noh J; Jhee JH; Chang TI; Kang EW; Kee YK; Kim H; Park S; Yun HR; Jung SY; Oh HJ; Park JT; Han SH; Kang SW; Kim C; Yoo TH
Stroke; 2017 Sep; 48(9):2472-2479. PubMed ID: 28801476
[TBL] [Abstract][Full Text] [Related]
11. Warfarin use and stroke, bleeding and mortality risk in patients with end stage renal disease and atrial fibrillation: a systematic review and meta-analysis.
Tan J; Liu S; Segal JB; Alexander GC; McAdams-DeMarco M
BMC Nephrol; 2016 Oct; 17(1):157. PubMed ID: 27769175
[TBL] [Abstract][Full Text] [Related]
12. Anticoagulation for atrial fibrillation in patients on dialysis: are the benefits worth the risks?
Shen JI; Turakhia MP; Winkelmayer WC
Curr Opin Nephrol Hypertens; 2012 Nov; 21(6):600-6. PubMed ID: 23079746
[TBL] [Abstract][Full Text] [Related]
13. Atrial fibrillation and warfarin use in haemodialysis patients: an individualized holistic approach is important in stroke prevention.
Thet Z; Vilayur E
Nephrology (Carlton); 2013 May; 18(5):331-9. PubMed ID: 23521615
[TBL] [Abstract][Full Text] [Related]
14. Prevention of stroke in patients with atrial fibrillation.
Olsson SB; Halperin JL
Semin Vasc Med; 2005 Aug; 5(3):285-92. PubMed ID: 16123916
[TBL] [Abstract][Full Text] [Related]
15. Warfarin Use, Stroke, and Bleeding Risk among Pre-Existing Atrial Fibrillation US Veterans Transitioning to Dialysis.
Sy J; Wenziger C; Marroquin M; Kalantar-Zadeh K; Kovesdy C; Streja E
Nephron; 2022; 146(4):360-368. PubMed ID: 35124673
[TBL] [Abstract][Full Text] [Related]
16. Anticoagulation for stroke prevention in new atrial fibrillation after coronary artery bypass graft surgery.
Schulman S; Cybulsky I; Delaney J
Thromb Res; 2015 May; 135(5):841-5. PubMed ID: 25776468
[TBL] [Abstract][Full Text] [Related]
17. Anticoagulants, renal failure and atrial fibrillation.
Genovesi S; Santoro A
Expert Opin Drug Saf; 2013 Jan; 12(1):1-3. PubMed ID: 23163428
[TBL] [Abstract][Full Text] [Related]
18. Systematic review and meta-analysis of incidence, prevalence and outcomes of atrial fibrillation in patients on dialysis.
Zimmerman D; Sood MM; Rigatto C; Holden RM; Hiremath S; Clase CM
Nephrol Dial Transplant; 2012 Oct; 27(10):3816-22. PubMed ID: 23114904
[TBL] [Abstract][Full Text] [Related]
19. Association Between Use of Warfarin for Atrial Fibrillation and Outcomes Among Patients With End-Stage Renal Disease: A Systematic Review and Meta-analysis.
Randhawa MS; Vishwanath R; Rai MP; Wang L; Randhawa AK; Abela G; Dhar G
JAMA Netw Open; 2020 Apr; 3(4):e202175. PubMed ID: 32250434
[TBL] [Abstract][Full Text] [Related]
20. Warfarin in haemodialysis patients with atrial fibrillation: what benefit?
Yang F; Chou D; Schweitzer P; Hanon S
Europace; 2010 Dec; 12(12):1666-72. PubMed ID: 21045011
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
